Medicis buys LipoSonix
This article was originally published in The Gray Sheet
Executive Summary
Privately held LipoSonix, which is developing a non-invasive, ultrasound technology-based system for body contouring as an alternative to invasive liposuction for fat reduction, is acquired by aesthetic dermal filler and pharmaceutical firm Medicis for $150 million on July 1. The deal calls for Medicis to pay up to an additional $150 million upon FDA approval of the technology "and if various commercial milestones are achieved on a worldwide basis," Medicis says. The firm anticipates FDA market go-ahead by 2011